In the news | 14th Apr 2023
How to speed up regulatory submission in drug development
Scott Weiss, Vice President, Business Development and Open Innovation, explores digital workflows with an “audit-by-exception” approach which helps speed up regulatory submission by reducing errors and time to compile data. This approach leads to greater transparency and better relationships with regulatory agencies and helps avoid delays to the market.
To learn more, read this article published in Drug Delivery & Development.
Ensuring product, process and patient data integrity and traceability throughout the BioPharmaceutical lifecycle in the era of personalized medicine
The BioPharma industry is facing a multitude of challenging external trends, from the growth in personalized medicine to supply chain disruptions and more.
European Biomanufacturing Summit 2023
Come and join us at booth 130 in Amsterdam, to learn how an innovative tech transfer approach can revolutionize drug manufacturing in the pharmaceutical industry.
IDBS events roundup: Q1 highlights and Q2 events
IDBS associates had the opportunity to attend some events in Q1 and attendees were eager to see, hear and learn more about what’s happening in the industry.
How to improve time-to-value using GxP computer systems
Explore the benefits of GxP computer systems to improve time-to-value so that companies can speed up the development and manufacture of life-saving drugs.